Shefali Agarwal

2020

In 2020, Shefali Agarwal earned a total compensation of $1.8M as Executive Vice President, Chief Medical and Development Officer at Epizyme, a 38% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$199,804
Option Awards$825,799
Salary$478,000
Stock Awards$274,990
Other$7,154
Total$1,785,747

Agarwal received $825.8K in option awards, accounting for 46% of the total pay in 2020.

Agarwal also received $199.8K in non-equity incentive plan, $478K in salary, $275K in stock awards and $7.2K in other compensation.

Rankings

In 2020, Shefali Agarwal's compensation ranked 6,042nd out of 13,090 executives tracked by ExecPay. In other words, Agarwal earned more than 53.8% of executives.

ClassificationRankingPercentile
All
6,042
out of 13,090
54th
Division
Manufacturing
2,488
out of 5,618
56th
Major group
Chemicals And Allied Products
997
out of 2,251
56th
Industry group
Drugs
863
out of 1,951
56th
Industry
Pharmaceutical Preparations
643
out of 1,456
56th

Pay ratio

Shefali Agarwal's Pay$1,785,747
Median Employee's Pay$333,249
Pay Ratio

5

to 1

In 2020, the annual total compensation of Shefali Agarwal was $1,785,747.

The annual total compensation of the median employee at Epizyme was $333,249.

The ratio of Shefali Agarwal's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 29, 2021.

Agarwal's colleagues

We found four more compensation records of executives who worked with Shefali Agarwal at Epizyme in 2020.

2020

Robert Bazemore

Epizyme

Chief Executive Officer

2020

Jeffery Kutok

Epizyme

Chief Scientific Officer

2020

Paolo Tombesi

Epizyme

Chief Financial Officer

2020

Matthew Ros

Epizyme

Executive Vice President, Chief Strategy and Business Officer

News

You may also like